News I-Mab

Equities

IMAB

US44975P1030

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
1.755 ^USD	+0.29%		-3.04%	-7.63%

Apr. 18	Verastem Names John Hayslip as Chief Medical Officer	MT
Apr. 15	I-Mab Announces Chief Medical Officer Changes	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

I-MAB Filed 2023 Annual Report on Form 20-F	Apr. 30	PR
Verastem Names John Hayslip as Chief Medical Officer	Apr. 18	MT
I-Mab Announces Chief Medical Officer Changes	Apr. 15	CI
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference	Apr. 08	AQ
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference	Apr. 05	PR
I-Mab Completes Business Divestiture in China	Apr. 02	MT
I-Mab Announces Closing of the Divestiture of Business Operations in China	Apr. 02	PR
I-mab Biopharma Co., Ltd. completed the acquisition of I-Mab Biopharma Co., Ltd. from I-Mab.	Apr. 01	CI
I Mab : Resignations of Director and Senior Management - Form 6-K	Apr. 01	PU
I-Mab Announces Executive Resignation	Apr. 01	CI
Piper Sandler Adjusts Price Target on I-Mab to $10 From $15, Maintains Overweight Rating	Mar. 18	MT
Needham Cuts Price Target on I-Mab to $6 From $8, Maintains Buy Rating	Mar. 15	MT
I-Mab Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
Gilead Sciences pauses enrollment for cancer treatment in solid tumor trials	Feb. 15	RE
I-Mab Divests China Operations, Shifts Focus to US Market	Feb. 08	MT
ADRs Close Higher, Renalytix PLC Climbs 96.9%	Feb. 08	DJ
I-Mab Signs Agreement to Divest its Assets and Business Operations in China	Feb. 08	AQ
Biotech firm I-Mab to divest China operations, shift focus to US	Feb. 07	RE
Biotech firm I-Mab to divest China operations	Feb. 07	RE
I-Mab Announces Board Changes , Effective February 10, 2024	Feb. 07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW